Latest News

CanalLotus Biotech news and insights

FDA Approves Xbryk (denosumab-dssb), a Biosimilar to Xgeva

INCHEON, Korea – Feb 16, 2025 -- Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Xbryk (denosumab-ds

Latest News NDA News 1699
• Read All

FDA Approves Gomekli (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

STAMFORD, Conn., Feb. 11, 2025 -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the U.S.

Latest News NDA News 1471
• Read All

FDA Approves Emblaveo (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections

NORTH CHICAGO, Ill., Feb. 7, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved Emblaveo™ (aztreonam and avibactam), as the first an

Latest News NDA News 1713
• Read All

Mr. James Ho, the founder of CliniExpert, was invited to attend the 71st Indian Pharmaceutical Congress and was awarded the International Contribution Award

On December 20-22, 2019, at the invitation of the Committee of Indian Drug Control Officials, Mr. James Ho, CEO of Beijing Memorial Pharmaceutical Research Co., Ltd. went to Chennai, the fourth larges

Latest News Company Update 2614
• Read All

Organized by Cliniexpert, China Pharma Summit 2021 in Beijing & First China International Generic Drug Development Forum was Successfully Held

From June 3 to 4, 2021, the "China Pharma Summit 2021 in Beijing & First China International Generic Drug Development Forum" hosted by Beijing Memorial Pharmaceutical Research Co., Ltd.

Latest News Company Update 2673
• Read All

Try the best and demand every team member as the one who Keeps His Word. - James Ho

China Industrial Economy News reporter Linlin Zhao -- Over the past 40 years of reform and opening up, the ranks of small and medium-sized enterprises have become larger and larger, and they have beco

Latest News Company Update 2604
• Read All

James Ho, Founder of The CliniExpert Answered Questions of Reportes

Q:Would you give us a brief about CliniExpert? James Ho:Based in China, we are offering services to the global pharmaceutical research industry, esp. for the supply of the investigational product. We

Latest News Company Update 2560
• Read All

In the "post-epidemic" era, How Can Chinese Clinical Comparators Save Your Cost ?

What is the "post-epidemic" era? My colleague Mr.Zhang once used to having noodles for lunch in the restaurant which is near the company for several years. But in 2020, this restaurant was c

Latest News Company Update 2753
• Read All

FDA Approves Onapgo (apomorphine hydrochloride) for the Treatment of Motor Fluctuations in Adults with Advanced Parkinson’s Disease

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of cen

Latest News NDA News 1637
• Read All

FDA Approves Journavx (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

BOSTON--(BUSINESS WIRE)--Jan. 30, 2025 -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine), an or

Latest News NDA News 1668
• Read All

FDA Approves Symbravo (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today an

Latest News NDA News 2363
• Read All

FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar to Actemra

JERSEY CITY, N.J., Jan. 30, 2025 -- Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved Avtozma® (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutan

Latest News NDA News 1440
• Read All
News
Gloved hands holding a globe, global clinical trial drug sourcing
- CanalLotus Biotech -
Int'l Clinical Service Expert

We are the leader
Because of our professionism

WhatsApp Service QR code